February 22, 2018

Biotechnology, Life Sciences, Food and Drug Law News

The National Law Review features a wide variety of content on issues important to life sciences companies, including biosimilars, biotechnology, medical devices, drug pricing, nanotechnology, and pharmaceuticals.  Our content reviews the impact the latest legal changes have on these industries, such as the 21st Century Cures Act. With all of these areas, our content covers issues such as licensing and patents, intellectual property, due diligence, litigation and tax implications.

We also have legal expertise on marketing compliance, licensing and collaborations, and bringing new products to market.  Additionally, the National Law Review is a source for all the latest legal news and regulatory compliance issues involving food and cosmetics safety and labeling requirements, activities of the Food and Drug Administration (“FDA”) and the US Department of Agriculture (“USDA”).

Date Title Organization
21
Feb
Amicus Briefs Filed in Support of Deeming Rule Appeal by Washington Legal Foundation, NJOY, CASAA, the State of Iowa and Clive Bates, et al. Keller and Heckman LLP
21
Feb
Maine Recreational Marijuana Law Limits Workplace Drug Testing As Well As Disciplinary Consequences Imposed By Employers Jackson Lewis P.C.
21
Feb
2016 Drug Overdose Death Rate 3-Times Higher than in 1999 Risk and Insurance Management Society, Inc. (RIMS)
21
Feb
No Judges Equals No Judgments: Administrative Confusion at USDA Morgan, Lewis & Bockius LLP
21
Feb
USDA Extends Comment Period for Proposed Rule to “Modernize” Pork Inspection Keller and Heckman LLP
20
Feb
E-Cigarettes Gateway to Conventional Cigarette Smoking Stark & Stark
20
Feb
District Court Issues Opinion in Old Charter Bourbon False Advertising Class Action McDermott Will & Emery
20
Feb
EU Comments on India’s Draft Food Packaging Regulations Keller and Heckman LLP
20
Feb
FDA Updates Spice Risk Profile Keller and Heckman LLP
20
Feb
Federal Enforcement Actions Continue to Focus on Opioid-Related Misconduct Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
20
Feb
Are These INOMax Therapeutic Method Claims Directed To A Natural Phenomenon? Foley & Lardner LLP
20
Feb
Over 30% of New Drug Approvals in 2017 were Personalized Medicines Foley & Lardner LLP
17
Feb
JRC Opens Call to Access JRC Nanobiotechnology Laboratory Bergeson & Campbell, P.C.
16
Feb
Pharmaceutical Companies Reportedly Paid $10 Million to Encourage Use of Opioids Clifford Law Offices
16
Feb
White House 2019 Budget and White Paper Shape Ambitious Policy to Reduce Drug Prices Epstein Becker & Green, P.C.
16
Feb
New EU Regulation Sets BPA Limit in Food-Contact Varnishes and Coatings and Reduces Limit for BPA in Food-Contact Plastic Materials and Articles Keller and Heckman LLP
16
Feb
A Declaration without a Response: Senators Urge DEA to Enact Regulations on Opioid-Based Addiction Treatments Using Telemedicine McDermott Will & Emery
16
Feb
Proposed 2019 Budget Seeks Major Revamp to USDA’s Supplemental Nutrition Assistance Program (SNAP) Keller and Heckman LLP
16
Feb
DOE National Lab Develops Supertough Bioplastic Bergeson & Campbell, P.C.
15
Feb
EPA Increases FIFRA Maximum Civil Penalty Amount Keller and Heckman LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, February 27, 2018
Wednesday, February 28, 2018
Wednesday, February 28, 2018
Sunday, March 4, 2018
Wednesday, March 14, 2018
Wednesday, April 11, 2018
Thursday, April 19, 2018
Wednesday, May 9, 2018